Correlation Between Sabre Corpo and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sabre Corpo and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabre Corpo and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabre Corpo and Spyre Therapeutics, you can compare the effects of market volatilities on Sabre Corpo and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabre Corpo with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabre Corpo and Spyre Therapeutics.
Diversification Opportunities for Sabre Corpo and Spyre Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sabre and Spyre is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Sabre Corpo and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Sabre Corpo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabre Corpo are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Sabre Corpo i.e., Sabre Corpo and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Sabre Corpo and Spyre Therapeutics
Given the investment horizon of 90 days Sabre Corpo is expected to generate 2.38 times less return on investment than Spyre Therapeutics. But when comparing it to its historical volatility, Sabre Corpo is 1.19 times less risky than Spyre Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,986 in Spyre Therapeutics on September 2, 2024 and sell it today you would earn a total of 857.00 from holding Spyre Therapeutics or generate 43.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sabre Corpo vs. Spyre Therapeutics
Performance |
| Timeline |
| Sabre Corpo |
| Spyre Therapeutics |
Sabre Corpo and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sabre Corpo and Spyre Therapeutics
The main advantage of trading using opposite Sabre Corpo and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabre Corpo position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| Sabre Corpo vs. Expedia Group | Sabre Corpo vs. Trip Group Ltd | Sabre Corpo vs. Booking Holdings | Sabre Corpo vs. Despegar Corp |
| Spyre Therapeutics vs. Tff Pharmaceuticals | Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. Inhibrx | Spyre Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |